Patent · US Active

Materials and methods for improved immunoglycoproteins

US7846434B2 · kind B2 · utility

2Cited by

3References

17Claims

0Family size

Assignee

Trubion Pharmaceuticals, Inc. · US

Inventors

Erik Stephen Espling · Seattle, US
Peter Armstrong Thompson · Bellevue, US
Peter Robert Baum · Seattle, US

Key dates

Filing date	Apr 11, 2008
Grant date	Dec 7, 2010
Priority date	—
Expiry date	Apr 11, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/734
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Immunoglycoproteins, including antibodies, with improved ADCC and altered glycosylation patterns are provided. Also provided are cell culturing methods and media for producing such immunoglycoproteins, and therapeutic uses of such immunoglycoproteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.